Results 11 to 20 of about 43,334 (219)

Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and communityacquired pneumonia: A prospective observational study [PDF]

open access: yesCurrent Medical Mycology, 2022
Background and Purpose: Influenza A and SARS-CoV-2 are risk factors for invasive pulmonary aspergillosis. Both influenza-associated pulmonary aspergillosis and COVID-19-associated pulmonary aspergillosis result in high mortality and poor clinical ...
Ahsan Syed   +7 more
doaj   +1 more source

Therapeutic effects of Rheumatoid Arthritis on Aspergillosis development [PDF]

open access: yesReviews in Clinical Medicine, 2020
Aspergillosis is a common fungal infection with systemic characteristics, which is caused by various species of Aspergillus. The infection could develop in immunocompromised and immunocompetent patients under specific circumstances. Based on the clinical
Ali AL-Janabi
doaj   +1 more source

Pleuropulmonary aspergillosis in an immunocompetent patient presenting as pleural-based peripheral lung mass: A sporadic occurrence

open access: yesJournal of Association of Pulmonologist of Tamil Nadu, 2021
The importance of knowledge about pulmonary aspergillosis has increased immensely in the era of COVID-19 as a significant number of post-COVID patients develop lung infection with aspergillosis, an entity called COVID-associated pulmonary aspergillosis ...
P Amal Johnson   +2 more
doaj   +1 more source

Metagenomic next-generation sequencing for the diagnosis of pulmonary aspergillosis in non-neutropenic patients: a retrospective study

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
This study aimed to obtain further in-depth information on the value of metagenomic next-generation sequencing (mNGS) for diagnosing pulmonary aspergillosis in non-neutropenic patients.
Shujun Bao   +4 more
doaj   +1 more source

Successful long-term terbinafine therapy in an asthmatic patient with Aspergillus sensitization and bronchiectasis

open access: yesMedical Mycology Case Reports, 2017
Severe asthma with fungal sensitization (SAFS) is estimated to affect ~25% of patients with poorly controlled asthma. Tri-azole therapy is effective in only 60–80% and side effects are common.
Isabel Rodriguez-Goncer   +2 more
doaj   +1 more source

Nebulised N-Acetylcysteine for Unresponsive Bronchial Obstruction in Allergic Brochopulmonary Aspergillosis: A Case Series and Review of the Literature

open access: yesJournal of Fungi, 2018
Many chronic lung diseases are characterized by the hypersecretion of mucus. In these conditions, the administration of mucoactive agents is often indicated as adjuvant therapy. N-acetylcysteine (NAC) is a typical example of a mucolytic agent.
Akaninyene Otu   +2 more
doaj   +1 more source

Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature

open access: yesEuropean Journal of Medical Research, 2011
Major progress for the management of invasive aspergillosis has come from the introduction of new antifungals since the late 1990s. Although mortality of invasive aspergillosis remains as high as 30-50%.
Karthaus M
doaj   +1 more source

CLINICAL CASE OF CHRONIC PULMONARY ASPERGILLOSIS IN PATIENT WITH DRUG-RESISTANT PULMONARY TUBERCULOSIS

open access: yesŽurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, 2020
Chronic pulmonary aspergillosis (CPA) is a disease which is diffcult to diagnose and which complicates other respiratory diseases. Forms of CPA include chronic cavitary pulmonary aspergillosis, chronic fbrosing pulmonary aspergillosis, simple ...
Demidik S. N.   +5 more
doaj   +1 more source

Prevalence of pulmonary aspergillosis among chronic obstructive pulmonary disease patients presented with acute exacerbation

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2019
Introduction Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a major event through the life of all chronic obstructive pulmonary disease (COPD) patients.
Mostafa Shawki, H.M. Abdel-Hamid
doaj   +1 more source

Renal aspergillosis after COVID‐19‐associated pulmonary aspergillosis: A case report

open access: yesClinical Case Reports, 2023
Key Clinical Message Renal aspergillosis is a rare condition and this case the first case of Renal aspergillosis reported after COVID‐19‐associated pulmonary aspergillosis. Renal symptoms should arise clinical suspicion to renal involvement that happened
Roya Ghasemian   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy